MINNEAPOLIS, Minn. – Intensive remote therapy improved blood glucose control in pediatric patients with Type 1 diabetes, according to a study published recently in Pediatric Diabetes.
Results show the intensive remote therapy group experience increased glycemic control after six months by reducing glycated hemoglobin by 0.34, compared to 0.05 in the conventional care group. They also show that diabetes-related quality of life increased by 6.5 points in the remote therapy group, compared to 1.3 points in the conventional care group.
“IRT substantially affected diabetes metrics and improved quality of life among pediatric patients with T1D,” wrote Laura Gandrud, an author of the study.
Researchers from Children’s Minnesota and UnitedHealth ran the six-month study, which included 117 pediatric patients with Type 1 diabetes. Intensive remote therapy was used with 60 patients, with the remaining patients receiving conventional care.
Both groups continued clinic visits and uploaded data collected from their diabetes devices. The remote therapy group received messages from their providers with changes in care that were needed.